Clinical Trials Directory

Trials / Unknown

UnknownNCT03754517

Finding the Latent Treponema Pallidum

Finding the Latent Treponema Pallidum of Syphilis With Serofast Status

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Some syphilitic patients remain in a serologically positive state after the recommended therapy. Whether a serofast state could represent a persistent low-level infection by Treponema pallidum is still unknown. The possibility that persistent nontreponemal antibodies after treatment represent persistence of Treponema pallidum was raised by some investigators. The investigators use the Next-Generation Sequencing to test blood plasma, srum, cerebrospinal fluid, aqueous humor, lymph nodes, skin lesion, saliva, semen,milk of serofast patient and other positive and negative controls.

Detailed description

Some syphilitic patients remain in a serologically positive state after the recommended therapy. Whether a serofast state could represent a persistent low-level infection by Treponema pallidum is still unknown. The possibility that persistent nontreponemal antibodies after treatment represent persistence of Treponema pallidum was raised by some investigators. The investigators use the Next-Generation Sequencing to test blood plasma, serum, cerebrospinal fluid, aqueous humor, lymph nodes, skin lesion, saliva, semen,milk of serofast patient and other positive and negative controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRPR TiterRPR titer; TPPA/FTA-ABS; Next-Generation Sequencing

Timeline

Start date
2016-08-01
Primary completion
2019-11-01
Completion
2019-12-01
First posted
2018-11-27
Last updated
2019-03-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03754517. Inclusion in this directory is not an endorsement.